| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9954452 | European Journal of Cancer | 2018 | 13 Pages |
Abstract
The SurPass is potentially an essential tool for improved and more harmonised follow-up of CCS. It also has the potential to be a useful tool for empowering CCSs to be responsible for their own well-being and preventing adverse events whenever possible. With sufficient commitment on the European level, this solution should increase the capacity to respond more effectively to the needs of European CCS.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Riccardo Haupt, Samira Essiaf, Chiara Dellacasa, Cecile M. Ronckers, Silvia Caruso, Elaine Sugden, Lorna Zadravec Zaletel, Monica Muraca, Vera Morsellino, Anita Kienesberger, Anne Blondeel, Davide Saraceno, Maurizio Ortali, Leontien C.M. Kremer,